Cargando…
Real‐world dose adjustments of biologic treatments in psoriasis and their economic impact: a Swedish national population study
BACKGROUND: To date, evidence on the dose adjustments of biologics in the real‐world treatment of psoriasis is limited. However, dose adjustments may have important clinical and economic implications. AIMS: To study the dose adjustments of individual biologics over time in real‐world practice in Swe...
Autores principales: | Egeberg, Alexander, Freilich, Jonatan, Stelmaszuk, M. Natalia, Kongerslev, Rikke, Apol, Eydna, Hansen, Jes Birger, Levin, Lars‐Åke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826076/ https://www.ncbi.nlm.nih.gov/pubmed/35670046 http://dx.doi.org/10.1111/ced.15288 |
Ejemplares similares
-
Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study
por: Schmitt-Egenolf, Marcus, et al.
Publicado: (2021) -
Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison
por: Hampton, Philip, et al.
Publicado: (2021) -
Treatment Patterns among Patients with Atopic Dermatitis in Secondary Care: A National, Observational, Non-interventional, Retrospective Study in Sweden
por: JOHANSSON, Emma K., et al.
Publicado: (2022) -
Dermatology Life Quality Index in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab or Ustekinumab
por: Lambert, Jo, et al.
Publicado: (2021) -
Disease burden and treatment sequence of polymyositis and dermatomyositis patients in Japan: a real-world evidence study
por: Miyazaki, Celine, et al.
Publicado: (2021)